22 May 2013
Keywords: patients, using, b-ms, zerit, do, better, after
Article | 29 May 1995
- New data from the ACTG 019 study of Bristol-Myers Squibb's Zerit
(stavudine) has shown that patients who had been using Glaxo ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 1995
22 May 1995
5 June 1995
© 2013 thepharmaletter.com